BCV
BMY icon

Banque Cantonale Vaudoise’s Bristol-Myers Squibb BMY Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.86M Buy
113,102
+10,555
+10% +$615K 0.26% 70
2025
Q4 		$5.53M Sell
102,547
-25,225
-20% -$1.21M 0.2% 96
2025
Q3 		$5.76M Buy
127,772
+26,347
+26% +$1.23M 0.22% 84
2025
Q2 		$4.7M Sell
101,425
-85,224
-46% -$4.18M 0.19% 98
2025
Q1 		$11.4M Buy
+186,649
New +$10.9M 0.5% 32
2024
Q3 		$8.36M Sell
161,522
-4,830
-3% -$227K 0.34% 57
2024
Q2 		$6.91M Buy
166,352
+21,443
+15% +$959K 0.27% 61
2024
Q1 		$7.86M Buy
144,909
+37,663
+35% +$1.92M 0.31% 60
2023
Q4 		$5.5M Sell
107,246
-13,462
-11% -$707K 0.24% 77
2023
Q3 		$7M Sell
120,708
-5,771
-5% -$354K 0.35% 52
2023
Q2 		$8.09M Buy
126,479
+10,784
+9% +$723K 0.38% 54
2023
Q1 		$8.02M Buy
115,695
+8,635
+8% +$609K 0.39% 46
2022
Q4 		$7.7M Buy
107,060
+29,249
+38% +$2.21M 0.4% 44
2022
Q3 		$5.53M Sell
77,811
-11,984
-13% -$869K 0.32% 59
2022
Q2 		$6.92M Buy
89,795
+16,644
+23% +$1.27M 0.36% 51
2022
Q1 		$5.34M Buy
73,151
+8,059
+12% +$541K 0.23% 82
2021
Q4 		$4.06M Sell
65,092
-3,029
-4% -$178K 0.16% 129
2021
Q3 		$4.03M Buy
68,121
+763
+1% +$50.2K 0.17% 109
2021
Q2 		$4.5M Sell
67,358
-1,113
-2% -$72.6K 0.2% 101
2021
Q1 		$4.32M Sell
68,471
-784
-1% -$48.8K 0.22% 93
2020
Q4 		$4.3M Sell
69,255
-11,669
-14% -$718K 0.24% 87
2020
Q3 		$4.88M Sell
80,924
-8,266
-9% -$498K 0.31% 58
2020
Q2 		$5.24M Buy
89,190
+41,395
+87% +$2.48M 0.38% 55
2020
Q1 		$2.66M Buy
47,795
+1,000
+2% +$61.1K 0.23% 90
2019
Q4 		$3M Buy
+46,795
New +$2.68M 0.21% 103

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Cantonale Vaudoise's BMY Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its Bristol-Myers Squibb (BMY) stake by 10% in Q1 2026, buying an estimated $615K and bringing the position to 113,102 shares worth $6.86M. The position accounts for 0.26% of the portfolio, ranked #70.

Banque Cantonale Vaudoise first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. The position peaked at $11.4M in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Banque Cantonale Vaudoise held 113,102 shares of Bristol-Myers Squibb worth $6.86M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 10,555 Bristol-Myers Squibb shares in Q1 2026, an estimated $615K.
  • Bristol-Myers Squibb made up 0.26% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #70 holding.
  • Banque Cantonale Vaudoise first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's Bristol-Myers Squibb position peaked at $11.4M in Q1 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.